Regulation of PECAM-1 in endothelial cells during cell growth and migration

Experimental Biology and Medicine

Volumn 226, Issue 7, 2001, Pages 686-691

  Raychaudhury, Amlan ^a,c   Elkins, Marne ^a   Kozien, Dianna ^a   Nakada, Marian T ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b CENTOCOR INC   (United States)

^c NONE   (United States)

Author keywords

Angiogenesis; Endothelial cell; PECAM 1 (CD31); Reendothelialization; Tensegrity; TGF 1

Indexed keywords

CD31 ANTIGEN; MITOMYCIN C; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL KINETICS; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; STEADY STATE;

EID: 0034942713     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222600715     Document Type: Article

References (25)

1. EndoCAM: A novel endothelial cell-cell adhesion molecule
2. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions
3. Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo
4. Platelet endothelial cell adhesion molecule (CD31)
5. Involvement of endothelial PECAM-1/CD31 in angiogenesis
6. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels
7. Molecular mechanisms regulating the vascular endothelial cell motile response to injury
8. Control of capillary growth and differentiation by extracellular matrix: Use of a tensegrity (tensional integrity) mechanism for signal processing
9. Cellular tensegrity: Defining the rules of biological design that govern the cytoskeleton
10. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment
11. Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide
12. Vascular endothelial platelet endothelial cell adhesion molecule-1 (PECAM-1) expression is decreased by TNF-α and IFN-γ
13. Vascular-endothelial cadherin (CD144) but not PECAM-1- (CD31) based cell-to-cell contacts convey the maintenance of a quiescent endothelial monolayer
14. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cells
15. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth
16. Differential sensitivity of cultured endothelial cells to peroxynitrite and hydrogen peroxide toxicity: In Vitro
17. Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-betal correlates with reciprocal effects on cell migration
18. Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells
19. Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype
20. In vitro characteristics of neonatal hemangioma endothelial cells: Similarities and differences between normal neonatal and fetal endothelial cells
21. Divergent effects of extracellular oxygen on the growth, morphology, and function of human skin microvascular endothelial cells
22. PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated β-catenin
23. A new role for platelet endothelial cell adhesion molecule-1 (CD31): Inhibition of TCR-mediated signal transduction
24. PECAM-1 is required for transendothelial migration of leukocytes
25. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo